Show simple item record

dc.contributor.authorGunel, Tuba
dc.contributor.authorHosseini, Mohammad Kazem
dc.contributor.authorBenian, Ali
dc.contributor.authorAYDINLI, Kılıç
dc.contributor.authorGumusoglu, Ece
dc.date.accessioned2021-03-05T17:08:27Z
dc.date.available2021-03-05T17:08:27Z
dc.date.issued2018
dc.identifier.citationHosseini M. K. , Gunel T., Gumusoglu E., Benian A., AYDINLI K., "MicroRNA expression profiling in placenta and maternal plasma in early pregnancy loss", MOLECULAR MEDICINE REPORTS, cilt.17, sa.4, ss.4941-4952, 2018
dc.identifier.issn1791-2997
dc.identifier.othervv_1032021
dc.identifier.otherav_c4249e8a-5eec-47a5-b9c1-25e3f131bfa6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/130088
dc.identifier.urihttps://doi.org/10.3892/mmr.2018.8530
dc.description.abstractEarly pregnancy loss (EPL), also termed early miscarriage, is determined as the unintentional expulsion of an embryo or fetus prior to the 12th week of gestation. EPL frequency is similar to 15% in pregnancies. Fetal development and growth is associate with placental function and vessel development; therefore, the placental genome would represent a useful miscarriage model for (epi)genetic and genomic studies. An important factor of placental development and function is epigenetic regulation of gene expression. microRNAs (miRNAs) are the primary epigenetic regulators which have an important role in placental development and function. In the present study, maternal plasma and villous tissue were collected from 16 EPL cases in 6th-8th gestational weeks (GWs) and 8 abortions (control group) in 6th-8th GWs. Detection of the differences in miRNA expression was performed using microarrays and dysregulated miRNAs were validated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). miRNA microarray findings revealed that four miRNAs, including hsa-miRNA (miR)-125a-3p, hsa-miR-3663-3p, hsa-miR-423-5p and hsa-miR-575 were upregulated in tissue samples. In maternal plasma, two miRNAs (hsa-let-7c, hsa-miR-122) were upregulated and one miRNA (hsa-miR-135a) was downregulated. A total of 6 out of 7 dysregulated miRNAs were validated using RT-qPCR. The target genes of these dysregulated miRNAs were detected using the GeneSpring database. The aim of the present study was to detect dysregulated miRNAs in maternal plasma and villous cells and identify the target genes of dysregulated miRNAs and their associated pathways. The target gene analyses have revealed that the affected genes are primarily associated with cell migration, proliferation, implantation, adhesion, angiogenesis and differentiation and all are involved with EPL pathogenesis. Therefore, the present study may contribute to the understanding of the molecular mechanisms which lead to EPL.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectTıp
dc.titleMicroRNA expression profiling in placenta and maternal plasma in early pregnancy loss
dc.typeMakale
dc.relation.journalMOLECULAR MEDICINE REPORTS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume17
dc.identifier.issue4
dc.identifier.startpage4941
dc.identifier.endpage4952
dc.contributor.firstauthorID64567


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record